Literature DB >> 16613594

Liver and intestine transplantation in the United States, 1995-2004.

M L Shiffman1, S Saab, S Feng, M I Abecassis, A G Tzakis, N P Goodrich, D E Schaubel.   

Abstract

Three years of survival data are now available and the impact of the model for end-stage liver disease (MELD) allocation system is becoming clear. After a decline in new registrants to the waiting list in 2002, the number increased to 10 856 new patients in 2004. Since the implementation of MELD, the percentage of patients who have been on the list for 1-2 years has declined from 24% to 19%. There has been a shift upward in the percentage of patients with higher MELD scores on the waiting list. An increasing percentage of adult living donor liver recipients are over the age of 50 years; from 1% in 1997 to 51% in 2004. Parents donating to children (93% of living donors in 1995), represented only 14% in 2004. Long-term adjusted patient survival declined with increasing recipient age in adults following either DDLT or LDLT. Cirrhosis caused by chronic hepatitis C virus (HCV) is the leading indication for liver transplantation and is associated with reduced long-term survival in recipients with HCV compared to those without HCV, 68% at 5 years compared to 76%. Although the intestine waiting list has more than doubled over the last decade, an increasing number of centers now perform intestinal transplantation with greater success.

Entities:  

Mesh:

Year:  2006        PMID: 16613594     DOI: 10.1111/j.1600-6143.2006.01273.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  17 in total

1.  Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes.

Authors:  Ryan M Taylor; Timothy Davern; Santiago Munoz; Stephen-Huy Han; Brendan McGuire; Anne M Larson; Linda Hynan; William M Lee; Robert J Fontana
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

2.  Hepatic resection for large hepatocellular carcinoma in the era of UCSF criteria.

Authors:  Spiros G Delis; Andreas Bakoyiannis; Nikos Tassopoulos; Kostas Athanassiou; Aristotelis Kechagias; Dimitrios Kelekis; Juan Madariaga; Christos Dervenis
Journal:  HPB (Oxford)       Date:  2009-11       Impact factor: 3.647

3.  Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate.

Authors:  Daire O'Shea; John Law; Adrian Egli; Donna Douglas; Gary Lund; Sarah Forester; Joshua Lambert; Mansun Law; Dennis R Burton; D L J Tyrrell; Michael Houghton; Atul Humar; Norman Kneteman
Journal:  Liver Transpl       Date:  2016-01-29       Impact factor: 5.799

4.  Response to hepatitis A and B vaccine alone or in combination in patients with chronic hepatitis C virus and advanced fibrosis.

Authors:  Erik Seth Kramer; Charlotte Hofmann; Paula G Smith; Mitchell L Shiffman; Richard K Sterling
Journal:  Dig Dis Sci       Date:  2009-06-11       Impact factor: 3.199

5.  Liver transplantation.

Authors:  Deok-Bog Moon; Sung-Gyu Lee
Journal:  Gut Liver       Date:  2009-09-30       Impact factor: 4.519

6.  Adult Living Donor Liver Transplantation with ABO-Incompatible Grafts: A German Single Center Experience.

Authors:  Armin D Goralczyk; Aiman Obed; Andreas Schnitzbauer; Axel Doenecke; Tung Yu Tsui; Marcus N Scherer; Giuliano Ramadori; Thomas Lorf
Journal:  J Transplant       Date:  2010-02-03

7.  Kaposi's sarcoma after liver transplantation.

Authors:  Fabrizio Di Benedetto; Stefano Di Sandro; Nicola De Ruvo; Massimiliano Berretta; Michele Masetti; Roberto Montalti; Roberto Ballarin; Stefania Cocchi; Leonardo Potenza; Mario Luppi; Giorgio E Gerunda
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-09       Impact factor: 4.553

8.  Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes.

Authors:  Ying Shan; Jianyu Zheng; Richard W Lambrecht; Herbert L Bonkovsky
Journal:  Gastroenterology       Date:  2007-08-03       Impact factor: 22.682

9.  Ischemic Damage Represents the Main Risk Factor for Biliary Stricture After Liver Transplantation: A Follow-Up Study in a Danish Population.

Authors:  Barbara Lattanzi; Peter Ott; Allan Rasmussen; Karen Raben Kudsk; Manuela Merli; Gerda Elisabeth Villadsen
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

10.  Rapid reversal of parenteral-nutrition-associated cirrhosis following isolated intestinal transplantation.

Authors:  M Isabel Fiel; Hai-Shan Wu; Kishore Iyer; Gonzalo Rodriguez-Laiz; Thomas D Schiano
Journal:  J Gastrointest Surg       Date:  2009-05-06       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.